ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Renalytix PLC

Renalytix PLC (RNLX)

0.4315
0.0214
(5.22%)
終了 7月31日 5:00AM
0.4123
-0.0192
(-4.45%)
取引時間後: 8:52AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
0.4123
買値
0.4123
売値
0.4493
出来高
1,480,435
0.3881 日の範囲 0.4635
0.00 52 週間の範囲 0.00
時価総額
前日終値
0.4101
始値
0.46
最終取引時間
財務取引量
US$ 651,129
VWAP
0.439823
平均取引量 (3 か月)
-
発行済株式数
77,184,096
配当利回り
-
PER
-0.26
1 株当たり利益 (EPS)
-0.6
歳入
3.4M
純利益
-46.22M

Renalytix PLC について

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease ... Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. 詳細を表示

セクター
Services, Nec
業界
Services, Nec
ウェブサイト
本社
London, Gbr
設立
1970
Renalytix PLC is listed in the Services sector of the ナスダック市場 with ticker RNLX. The last closing price for Renalytix was US$0.41. Over the last year, Renalytix shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Renalytix currently has 77,184,096 shares in issue. The market capitalisation of Renalytix is US$31.65 million. Renalytix has a price to earnings ratio (PE ratio) of -0.26.

RNLX 最新ニュース

Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US

LONDON and NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical...

Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination

LONDON and NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (Nasdaq: RNLX) (LSE: RENX) announces that it has formally submitted a hearing request to the Nasdaq Hearings Panel...

Medicare Issues Final Coverage Determination for kidneyintelX.dkd

LONDON and NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that on June 13, 2024 Medicare issued a final Local Coverage Determination...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
IMNNImunon Inc
US$ 3.31
(178.15%)
141.23M
ATPCAgape ATP Corporation
US$ 0.1348
(54.06%)
198.44M
ISPOInspirato Inc
US$ 7.63
(45.61%)
32.23M
PCSAProcessa Pharmaceuticals Inc
US$ 2.2303
(31.19%)
58.01M
ONMDOneMedNet Corporation
US$ 1.45
(26.09%)
3.17M
QXOQXO Inc
US$ 12.15
(-79.92%)
19.25M
VBIVVBI Vaccines Inc
US$ 0.1242
(-77.67%)
20.55M
BIMIBIMI International Medical Inc
US$ 0.391
(-66.29%)
3.21M
CNSPCNS Pharmaceuticals Inc
US$ 0.4285
(-58.80%)
46.66M
RENBRenovaro Inc
US$ 0.662
(-43.66%)
1.15M
NVDANVIDIA Corporation
US$ 103.73
(-7.04%)
487.97M
SQQQProShares UltraPro Short QQQ
US$ 9.43
(4.20%)
202.98M
ATPCAgape ATP Corporation
US$ 0.1348
(54.06%)
198.44M
IMNNImunon Inc
US$ 3.31
(178.15%)
141.23M
TSLATesla Inc
US$ 222.62
(-4.08%)
101.01M

RNLX Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock